Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in the last two years.

Shares of biotech companies were outpacing the broader market on Thursday. The State Street SPDR S&P Biotech ETF was up 2.7%, compared with the 0.8% gain of the S&P 500. A significant portion of these ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, a biotechnology company focusing on extending the ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...